Bangladeshi - Kiingereza - DGDA (Directorate General of Drug Administration)

pharmadesh laboratories ltd. - chloramphenicol - suspension - 125 mg/5 ml

Kenya - Kiingereza - Pharmacy and Poisons Board

betaxolol hydrochloride - eye drops - 0.5%w/v - betaxolol

Marekani - Kiingereza - NLM (National Library of Medicine)

pharmaxx, inc. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - hand sanitizer gel to help reduce bacteria/germs that potentially can cause disease. for use when soap and water are not available.

Marekani - Kiingereza - NLM (National Library of Medicine)

pharmaxx, inc. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - alcohol sanitizer wipe to help reduce bacteria/germs that potentially can cause disease.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

pharmaxis ltd -

Kanada - Kiingereza - Health Canada

pharmaxis ltd - mannitol; mannitol; mannitol; mannitol - kit - 5mg; 10mg; 20mg; 40mg - mannitol 5mg; mannitol 10mg; mannitol 20mg; mannitol 40mg - diagnostic agents

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

btc speciality health pty ltd - mannitol, quantity: 0 mg - capsule, hard - excipient ingredients: gelatin - aridol is indicated for identifying bronchial hyperresponsiveness to assist in the diagnosis of asthma.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

syntara limited - mannitol, quantity: 40 mg - inhalation, powder for - excipient ingredients: - to assist in the treatment of bronchiectasis to assist in the treatment of cystic fibrosis identification of bronchial hyperresponsiveness to inhaled mannitol

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

btc speciality health pty ltd - mannitol, quantity: 40 mg - inhalation, powder for - excipient ingredients: gelatin - bronchitol is indicated for the treatment of cystic fibrosis (cf) in both paediatric and adult populations six years and above as either an add-on therapy to dornase alfa or in patients intolerant to, or inadequately responsive to dornase alfa.

Falme za Kiarabu - Kiingereza - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

pharmaxxi pharmaceutical products trading france - 5’s [5x5ml vials - solution - 1% - n/a